These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 373358)

  • 1. The effect of fenfluramine on obese, maturity-onset diabetic patients.
    Wales JK
    Acta Endocrinol (Copenh); 1979 Apr; 90(4):616-23. PubMed ID: 373358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenfluramine therapy in non-insulin-dependent diabetic patients: effects on body weight, glucose homeostasis, serum lipoproteins, and antipyrine metabolism.
    Salmela PI; Sotaniemi EA; Viikari J; Solakivi-Jaakkola T; Järvensivu P
    Diabetes Care; 1981; 4(5):535-40. PubMed ID: 6751729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of insulin-induced glucose disposal in obese patients with NIDDM after 1-wk treatment with d-fenfluramine.
    Scheen AJ; Paolisso G; Salvatore T; Lefèbvre PJ
    Diabetes Care; 1991 Apr; 14(4):325-32. PubMed ID: 2060435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of ponderal on the state of carbohydrate metabolism and insulin secretion in type 2 diabetes mellitus].
    Balabolkin MI; Novikova OM; Levitskaia ZI
    Sov Med; 1991; (11):56-9. PubMed ID: 1767320
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of a low-calorie diet with and without fenfluramine on the glucose tolerance and insulin secretion of obese maturity-onset diabetics.
    Dykes JR
    Postgrad Med J; 1973 May; 49(571):318-24. PubMed ID: 4804456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenformin compared with fenfluramine in the treatment of obese diabetic patients.
    Kesson CM; Ireland JT
    Practitioner; 1976 May; 216(1295):577-80. PubMed ID: 781656
    [No Abstract]   [Full Text] [Related]  

  • 8. Metabolic effects of fenfluramine in obese diabetics.
    Larsen S; Vejtorp L; Hornnes P; Bechgaard H; Sestoft L; Lyngsoe J
    Br J Clin Pharmacol; 1977 Oct; 4(5):529-33. PubMed ID: 334212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute and chronic effects of dexfenfluramine on glucose and insulin response to intravenous glucose in diabetic and non-diabetic obese subjects.
    Glaser B; Raveh Y; Norynberg C; Berry E; Lavielle R; Nathan C; Cerasi E
    Diabetes Res; 1992; 19(4):165-76. PubMed ID: 1343113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dexfenfluramine in obese Chinese NIDDM patients. A placebo-controlled investigation of the effects on body weight, glycemic control, and cardiovascular risk factors.
    Chow CC; Ko GT; Tsang LW; Yeung VT; Chan JC; Cockram CS
    Diabetes Care; 1997 Jul; 20(7):1122-7. PubMed ID: 9203448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of the obese non-insulin-dependent patient with d-fenfluramine].
    Daniele E; Coco MP
    Clin Ter; 1996 Apr; 147(4):199-204. PubMed ID: 8766352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weight reduction in obese diabetics: a double-blind study of diethylpropionate (author's transl)].
    Bratusch-Marrain P; Dudczak R; Waldhäusl W
    Wien Klin Wochenschr; 1979 Jun; 91(13):455-8. PubMed ID: 380178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fenfluramine in the treatment of non-insulin-dependent diabetics: hypoglycemic versus anorectic effect.
    Verdy M; Charbonneau L; Verdy I; Belanger R; Bolte E; Chiasson JL
    Int J Obes; 1983; 7(4):289-97. PubMed ID: 6629637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful appetite suppression therapy with fenfluramine and phentermine in the obese diabetic transplant patient.
    Khan M; Lum CT; Rao V
    Transplant Proc; 1995 Feb; 27(1):975-6. PubMed ID: 7879251
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the effects of 780SE on carbohydrate tolerance and plasma hormone and lipid profile in maturity-onset diabetes.
    Asmal AC; Leary WP
    Postgrad Med J; 1975; 51 Suppl 1(593):144-8. PubMed ID: 768955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoglycemic effect of fenfluramine in insulin-treated diabetics.
    Hamet P; Verdy I; Chiasson JL; Verdy M
    Clin Invest Med; 1986; 9(1):12-4. PubMed ID: 3514018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Obesity and diabetes. I. Blood sugar, blood insulin and NEFA during glucose tolerance test in obese subjects].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1969; 31(1):40-8. PubMed ID: 5402437
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of chromium and yeast supplements on carbohydrate and lipid metabolism in diabetic men.
    Rabinowitz MB; Gonick HC; Levin SR; Davidson MB
    Diabetes Care; 1983; 6(4):319-27. PubMed ID: 6352208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.